SCHEMBL2408211

SCHEMBL2408211

CC(CNC(=O)c1ccc(F)cc1)Cc1ccc(C(=O)NO)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.48
PPARG P37231 1/20 0.48
HDAC6 Q9UBN7 9/20 0.48
HDAC8 Q9BY41 7/20 0.48
HDAC1 Q13547 5/20 0.48
HDAC3 O15379 4/20 0.47
HDAC11 Q96DB2 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
ALOX12 P18054 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
NCOR2 Q9Y618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569859 0.77 HDAC6 (0.73) HDAC6HDAC8HDAC1HDAC3HDAC11
SCHEMBL6755639 0.77 ALDH1A1 (0.71) ALDH1A1LMNAALOX12SMN1; SMN2HDAC4
SCHEMBL2410147 0.76 HDAC6 (0.64) HDAC6HDAC8HDAC1ALDH1A1
SCHEMBL2470040 0.76 HDAC6 (0.70) HDAC6HDAC8HDAC1HDAC3HDAC11
SCHEMBL2736629 0.76 KMT2A (0.56) PPARGALDH1A1LMNASMN1; SMN2
SCHEMBL2409971 0.76 HDAC6 (0.67) HDAC6HDAC8HDAC1ALDH1A1LMNA
SCHEMBL8250757 0.75 LMNA (0.65) EPHX2PPARGLMNASMN1; SMN2
SCHEMBL6919015 0.75 HDAC6 (0.62) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL2413536 0.75 HDAC6 (0.56) EPHX2HDAC6HDAC8HDAC1ALDH1A1
SCHEMBL296885 0.74 HDAC6 (0.60) HDAC6HDAC8HDAC1HDAC3HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106632-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 WO disclosed